"Sertraline" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective serotonin uptake inhibitor that is used in the treatment of depression.
| Descriptor ID |
D020280
|
| MeSH Number(s) |
D02.092.705.800 D02.455.426.559.847.638.845.800 D04.615.638.845.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sertraline".
Below are MeSH descriptors whose meaning is more specific than "Sertraline".
This graph shows the total number of publications written about "Sertraline" by people in this website by year, and whether "Sertraline" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sertraline" by people in Profiles.
-
Sheline YI, Disabato BM, Hranilovich J, Morris C, D'Angelo G, Pieper C, Toffanin T, Taylor WD, MacFall JR, Wilkins C, Barch DM, Welsh-Bohmer KA, Steffens DC, Krishnan RR, Doraiswamy PM. Treatment course with antidepressant therapy in late-life depression. Am J Psychiatry. 2012 Nov; 169(11):1185-93.
-
Barch DM, D'Angelo G, Pieper C, Wilkins CH, Welsh-Bohmer K, Taylor W, Garcia KS, Gersing K, Doraiswamy PM, Sheline YI. Cognitive improvement following treatment in late-life depression: relationship to vascular risk and age of onset. Am J Geriatr Psychiatry. 2012 Aug; 20(8):682-90.
-
Davidson MB, Echeverry D. Collaborative care for depression and chronic illnesses. N Engl J Med. 2011 03 31; 364(13):1278; author reply 1278-9.
-
Sheline YI, Pieper CF, Barch DM, Welsh-Bohmer K, Welsh-Boehmer K, McKinstry RC, MacFall JR, D'Angelo G, Garcia KS, Gersing K, Wilkins C, Taylor W, Steffens DC, Krishnan RR, Doraiswamy PM. Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry. 2010 Mar; 67(3):277-85.
-
Vera M, Perez-Pedrogo C, Huertas SE, Reyes-Rabanillo ML, Juarbe D, Huertas A, Reyes-Rodriguez ML, Chaplin W. Collaborative care for depressed patients with chronic medical conditions: a randomized trial in Puerto Rico. Psychiatr Serv. 2010 Feb; 61(2):144-50.
-
Echeverry D, Duran P, Bonds C, Lee M, Davidson MB. Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care. 2009 Dec; 32(12):2156-60.
-
Csoka AB, Shipko S. Persistent sexual side effects after SSRI discontinuation. Psychother Psychosom. 2006; 75(3):187-8.
-
McRae AL, Brady KT, Mellman TA, Sonne SC, Killeen TK, Timmerman MA, Bayles-Dazet W. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder. Depress Anxiety. 2004; 19(3):190-6.
-
Apseloff G, Wilner KD, von Deutsch DA, Henry EB, Tremaine LM, Gerber N, Lazar JD. Sertraline does not alter steady-state concentrations or renal clearance of lithium in healthy volunteers. J Clin Pharmacol. 1992 Jul; 32(7):643-6.